PTPN3 and cholangiocarcinoma: From whole exome sequencing analysis, Gao et al. found that more than 40% of intrahepatic cholangiocarcinoma samples contain somatic mutations, and a frequent mutation of PTPN3–L232R was demonstrated to induce cholangiocarcinoma cell proliferation and migration and increased risk of tumor recurrence in patients [12].